| 000 | 01675 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513224249.0 | ||
| 264 | 0 | _c20010215 | |
| 008 | 200102s 0 0 eng d | ||
| 022 | _a0952-3278 | ||
| 024 | 7 |
_a10.1054/plef.2000.0213 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDarlametsos, I E | |
| 245 | 0 | 0 |
_aEffect of nifedipine in cyclosporine-induced nephrotoxicity in rats: roles of the thromboxane and endothelin systems. _h[electronic resource] |
| 260 |
_bProstaglandins, leukotrienes, and essential fatty acids _cNov 2000 |
||
| 300 |
_a263-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a6-Ketoprostaglandin F1 alpha _xurine |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aCreatinine _xurine |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacology |
| 650 | 0 | 4 |
_aDinoprostone _xurine |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEndothelin-1 _xurine |
| 650 | 0 | 4 |
_aEndothelins _xmetabolism |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aImmunoassay |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aNifedipine _xpharmacology |
| 650 | 0 | 4 | _aProteinuria |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aSpectrophotometry |
| 650 | 0 | 4 |
_aThromboxane B2 _xmetabolism |
| 650 | 0 | 4 | _aUrine |
| 700 | 1 | _aPapanikolaou, E N | |
| 700 | 1 | _aVaronos, D D | |
| 773 | 0 |
_tProstaglandins, leukotrienes, and essential fatty acids _gvol. 63 _gno. 5 _gp. 263-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1054/plef.2000.0213 _zAvailable from publisher's website |
| 999 |
_c11031858 _d11031858 |
||